CNBX Pharmaceuticals, Inc. (CNBX)
0.0001
0.00 (0.00%)
USD |
OTCM |
Sep 18, 16:00
CNBX Pharmaceuticals Net Income (TTM) : -0.4621M for May 31, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| May 31, 2026 | -0.4621M |
| February 28, 2026 | -0.3677M |
| November 30, 2025 | -0.3933M |
| August 31, 2025 | -0.314M |
| May 31, 2025 | -0.2245M |
| February 28, 2025 | -0.2954M |
| November 30, 2024 | -0.551M |
| August 31, 2024 | -0.6952M |
| May 31, 2024 | -1.208M |
| February 29, 2024 | -1.232M |
| November 30, 2023 | -3.531M |
| August 31, 2023 | -3.710M |
| May 31, 2023 | -3.616M |
| February 28, 2023 | -4.143M |
| November 30, 2022 | -2.758M |
| August 31, 2022 | -3.723M |
| May 31, 2022 | -3.925M |
| February 28, 2022 | -4.567M |
| November 30, 2021 | -3.863M |
| August 31, 2021 | -3.194M |
| May 31, 2021 | -3.245M |
| February 28, 2021 | -2.647M |
| November 30, 2020 | -2.98M |
| August 31, 2020 | -7.468M |
| May 31, 2020 | -8.129M |
| Date | Value |
|---|---|
| February 29, 2020 | -7.951M |
| November 30, 2019 | -3.353M |
| August 31, 2019 | 1.133M |
| May 31, 2019 | 1.794M |
| February 28, 2019 | 1.470M |
| November 30, 2018 | -3.895M |
| August 31, 2018 | -3.777M |
| May 31, 2018 | -4.147M |
| February 28, 2018 | -3.521M |
| November 30, 2017 | -2.324M |
| August 31, 2017 | -1.934M |
| May 31, 2017 | -0.8993M |
| February 28, 2017 | -0.6803M |
| November 30, 2016 | -0.3889M |
| August 31, 2016 | -0.2972M |
| May 31, 2016 | -0.4336M |
| February 29, 2016 | -0.5609M |
| November 30, 2015 | -0.4706M |
| August 31, 2015 | -0.543M |
| May 31, 2015 | -0.3939M |
| February 28, 2015 | -0.2723M |
| November 30, 2014 | -0.229M |
| May 31, 2014 | -0.1333M |
| February 28, 2014 | -0.0822M |
| November 30, 2013 | -0.0546M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Cocrystal Pharma, Inc. | -9.938M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 9.30M |
| Fulcrum Therapeutics, Inc. | -85.00M |
| Definium Therapeutics, Inc. | -353.78M |